Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1EP2006 (Filgrastim)
(D03235)		1件: Filgrastim1件: Filgrastim (D03235) 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65 💬
2Filgrastim
(D03235)		1件: Filgrastim1件: Filgrastim (D03235) 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬28件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
3Filgrastim (G-CSF)
(D03235)		1件: Filgrastim1件: Filgrastim (D03235) 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 331 💬
4Filgrastim Hexal
(D03235)		1件: Filgrastim1件: Filgrastim (D03235) 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65 💬
5Filgrastim, Alemtuzumab
(D03235)		2件: Alemtuzumab,
Filgrastim		2件: Alemtuzumab ,
Filgrastim (D03235) 💬 		2件: CD52,
CSF3R 💬 		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65 💬
6Granulocyte colony-stimulating factor (Filgrastim)
(D03235)		1件: Filgrastim1件: Filgrastim (D03235) 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 113 💬